NO20054172L - Nye blandinger - Google Patents

Nye blandinger

Info

Publication number
NO20054172L
NO20054172L NO20054172A NO20054172A NO20054172L NO 20054172 L NO20054172 L NO 20054172L NO 20054172 A NO20054172 A NO 20054172A NO 20054172 A NO20054172 A NO 20054172A NO 20054172 L NO20054172 L NO 20054172L
Authority
NO
Norway
Prior art keywords
new mixtures
mixtures
new
formulations
fentanyl
Prior art date
Application number
NO20054172A
Other languages
English (en)
Norwegian (no)
Other versions
NO20054172D0 (no
Inventor
Clive Booles
Calvin Ross
Alistair Campbell
Original Assignee
Arakis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0305579.5A external-priority patent/GB0305579D0/en
Application filed by Arakis Ltd filed Critical Arakis Ltd
Publication of NO20054172D0 publication Critical patent/NO20054172D0/no
Publication of NO20054172L publication Critical patent/NO20054172L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4468Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20054172A 2003-03-11 2005-09-07 Nye blandinger NO20054172L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0305579.5A GB0305579D0 (en) 2003-03-11 2003-03-11 Pharmaceutical compositions
GB0328023A GB2399286A (en) 2003-03-11 2003-12-03 Sub-lingual fentanyl formulation
PCT/GB2004/001037 WO2004080382A2 (en) 2003-03-11 2004-03-11 Novel compositions containing fentanyl

Publications (2)

Publication Number Publication Date
NO20054172D0 NO20054172D0 (no) 2005-09-07
NO20054172L true NO20054172L (no) 2005-10-06

Family

ID=32992592

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054172A NO20054172L (no) 2003-03-11 2005-09-07 Nye blandinger

Country Status (10)

Country Link
EP (1) EP1608372A2 (ja)
JP (1) JP2006519770A (ja)
KR (1) KR20050115276A (ja)
AU (1) AU2004218876B2 (ja)
BR (1) BRPI0408209A (ja)
CA (1) CA2516338A1 (ja)
MX (1) MXPA05009602A (ja)
NO (1) NO20054172L (ja)
NZ (1) NZ541781A (ja)
WO (1) WO2004080382A2 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5577021B2 (ja) * 2005-02-17 2014-08-20 アボット・ラボラトリーズ 動物における障害を治療および予防するための薬剤組成物の経粘膜投与
GB0514043D0 (en) * 2005-07-08 2005-08-17 Arakis Ltd Fentanyl formulation
DK1976521T3 (en) 2006-01-25 2015-04-27 Insys Therapeutics Inc Sublingual fentanyl spray
PT2180844T (pt) 2007-08-02 2018-04-06 Insys Dev Co Inc Nebulizador sub-lingual de fentanilo
GB2476494A (en) * 2009-12-24 2011-06-29 Norwich Pharma Technologies Ltd Formulation for the sublingual delivery of sufentanil

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2201358C (en) * 1994-09-30 2004-06-08 Jurgen Regenold Pharmaceutical composition
US20030185761A1 (en) * 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
EP2042161A1 (en) * 1997-10-01 2009-04-01 Novadel Pharma Inc. Propellant-free spray composition comprising anti-emetic agent
SE9803239D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab Composition for the treatment of acute pain
US6849263B2 (en) * 1998-12-21 2005-02-01 Generex Pharmaceutical Incorporated Pharmaceutical compositions for buccal delivery of pain relief medications
WO2000047203A1 (en) * 1999-02-12 2000-08-17 Mqs, Inc. Formulation and system for intra-oral delivery of pharmaceutical agents
AU2001262992A1 (en) * 2000-05-10 2002-02-18 University Of Kentucky Research Foundation System and method for intranasal administration of opioids
DE10064219B9 (de) * 2000-12-22 2009-02-12 Nasalis Pain Relief International Gmbh Neue Fentanyl und/oder dessen Derivate enthaltende pharmazeutische Zusammensetzung zur nasalen Anwendung

Also Published As

Publication number Publication date
CA2516338A1 (en) 2004-09-23
WO2004080382A3 (en) 2005-03-24
MXPA05009602A (es) 2005-11-08
BRPI0408209A (pt) 2006-02-14
WO2004080382A2 (en) 2004-09-23
NO20054172D0 (no) 2005-09-07
AU2004218876B2 (en) 2007-08-02
JP2006519770A (ja) 2006-08-31
AU2004218876A1 (en) 2004-09-23
EP1608372A2 (en) 2005-12-28
KR20050115276A (ko) 2005-12-07
NZ541781A (en) 2008-04-30

Similar Documents

Publication Publication Date Title
NO20060202L (no) Pyrrolodihydroisokinoliner som PDE-10-inhibitorer
NO20090596L (no) Antivirale fosfinatforbindelser
DK1682530T3 (da) Pyrrolsubstituerede indoler som inhibitorer af PAI-1
DK1881967T3 (da) Substituerede benzo (D) isoaxol-3-yl-amin-forbindelser som analgetika
NO20071078L (no) Antivirale forbindelser
NO20070866L (no) Antivirale forbindelser.
CY1111225T1 (el) Νεα πεπτιδια ως αναστολεις πρωτεασης νs3-σερινης ιου ηπατiτιδας c
ATE433447T1 (de) Pyrimiidinverbindungen
NO20045589L (no) Nye forbindelser
EA200802008A1 (ru) Фармацевтические композиции
SE0202241D0 (sv) Novel Compounds
BRPI1015043A2 (pt) derivados de diazahomoadamantano e métodos de uso dos mesmos
DE502006005053D1 (de) Spritzbare akustikmassen
NO20055612L (no) Anti-inflammatoriske fosfonatforbindelser
DK1635783T5 (da) Farmaceutiske sammensætninger omfattende fentanyl til intranasal levering
TNSN06012A1 (en) Emulsifying systems containing azetidine derivatives
ATE417849T1 (de) Pyrazoloä4,3-düpyrimidine
NO20055207L (no) Oralt farmasoytisk preparat for protonpumpeantagonister
NO20055396D0 (no) Nye fosfonsyreforbindelser som erinproteaseinhibitorer
NO20054172L (no) Nye blandinger
HRP20051005A2 (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
NO20063293L (no) Farmasoytiske forbindelser
ATE430148T1 (de) Neue pyrrolodihydroisochinoline als pde10- inhibitoren
AP1543A (en) Phenyl heterocyclyl ethers.
EA200600590A1 (ru) Фармацевтические композиции модафинила с модифицированным высвобождением

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application